Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Casey

Showing results (231-240 of 328) with videos related to

Pageof 33
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1996
Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor componentsM K Ganapathi, A K Weizer, S Borsellino, et al.
Human Vaccines & Immunotherapeutics|February 25, 2016
Listeria monocytogenes mutants defective in gallbladder replication represent safety-enhanced vaccine delivery platformsGeorgina C Dowd, Mohammed Bahey-El-Din, Pat G Casey, et al.
Cancer Research|July 26, 2000
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locusP L Paris, J S Witte, P A Kupelian, et al.
Cancer Letters|May 14, 1993
p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitisG Casey, Y Yamanaka, H Friess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosisS A Vaziri, L M Krumroy, P Elson, et al.
Cancer Gene Therapy|February 27, 2010
Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivationM C Whelan, G Casey, M MacConmara, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic diseaseM Tangney, G Casey, J O Larkin, et al.
BMC Biology|November 21, 2020
Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbationLorraine A Draper, Feargal J Ryan, Marion Dalmasso, et al.
Cancer|November 5, 1997
p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancerG H Eltabbakh, J L Belinson, A W Kennedy, et al.
Plos One|November 12, 2014
Divergent evolution of the activity and regulation of the glutamate decarboxylase systems in Listeria monocytogenes EGD-e and 10403S: roles in virulence and acid toleranceConor Feehily, Aiden Finnerty, Pat G Casey, et al.
Pageof 33

Showing results (231-240 of 328) with videos related to

Sort By:
Pageof 33
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1996
Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor componentsM K Ganapathi, A K Weizer, S Borsellino, et al.
Human Vaccines & Immunotherapeutics|February 25, 2016
Listeria monocytogenes mutants defective in gallbladder replication represent safety-enhanced vaccine delivery platformsGeorgina C Dowd, Mohammed Bahey-El-Din, Pat G Casey, et al.
Cancer Research|July 26, 2000
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locusP L Paris, J S Witte, P A Kupelian, et al.
Cancer Letters|May 14, 1993
p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitisG Casey, Y Yamanaka, H Friess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosisS A Vaziri, L M Krumroy, P Elson, et al.
Cancer Gene Therapy|February 27, 2010
Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivationM C Whelan, G Casey, M MacConmara, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic diseaseM Tangney, G Casey, J O Larkin, et al.
BMC Biology|November 21, 2020
Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbationLorraine A Draper, Feargal J Ryan, Marion Dalmasso, et al.
Cancer|November 5, 1997
p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancerG H Eltabbakh, J L Belinson, A W Kennedy, et al.
Plos One|November 12, 2014
Divergent evolution of the activity and regulation of the glutamate decarboxylase systems in Listeria monocytogenes EGD-e and 10403S: roles in virulence and acid toleranceConor Feehily, Aiden Finnerty, Pat G Casey, et al.
Pageof 33